Sub-chronic treatment with an extract of Hypericum perforatum (St John's wort) significantly reduces cortisol and corticosterone in the rat brain

European Neuropsychopharmacology

Volumn 14, Issue 1, 2004, Pages 7-10

  Franklin, Mike ^a   Reed, Alison ^a   Murck, Harald ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Lichtwer Pharma AG   (Germany)

Author keywords

Blood brain barrier; Corticosterone; Cortisol; Multidrug transporter glycoprotein; St John's wort

Indexed keywords

CORTICOSTERONE; CORTISONE; HYDROCORTISONE; HYPERICUM PERFORATUM EXTRACT; PLANT EXTRACT;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD; BRAIN; BRAIN LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; HORMONE DETERMINATION; HYPERICUM; MALE; METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

HYPERICUM PERFORATUM;

EID: 0345118054     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(03)00038-5     Document Type: Article

References (20)

1. Bhattacharya S.K., Chakrabarti A., Chatterjee S.S. Activity profiles of two hyperforin-containing Hypericum extracts in behavioral models. Pharmacopsychiatry. 31:1998;22-29.
2. Butterweck V., Wall A., Liefländer-Wulf U., Winterhoff H., Nahrstedt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry. 30:(Suppl. 2):1997;117-124.
3. Butterweck V., Korte B., Winterhoff H. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Pharmacopsychiatry. 34:(Suppl.):2001;S2-S7.
4. Calapai G., Crupi A., Firenzuoli F., Costantino G., Inferrera G., Campo G.M., Caputi A.P. Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat. J. Pharm. Pharmacol. 51:1999;723-728.
5. Carroll B.J., Curtis G.C., Mendels J. Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol. Med. 6:1976;235-244.
6. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer I., Riedler J.L., Melamed J.L., Bertino J.L. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood brain barrier sites. Proc. Natl. Acad. Sci. USA. 86:1989;695-698.
7. Dürr D., Stieger B., Kullak-Ublick G.A., Rentsch K.M., Steinert H.C., Meier P.J., Fattinger K. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther. 68:2000;598-604.
8. Franklin M., Chi J., McGavin C., Hockney R., Reed A., Campling G., Whale R.W., Cowen P.J. Neuroendocrine evidence for dopaminergic actions of Hypericum extract (LI 160) in healthy volunteers. Biol. Psychiatry. 46:1999;581-584.
9. Franklin M., Chi J., Mannel M., Cowen P.J. Acute effects of LI 160 (extract of Hypericum perforatum, St John's wort) and two of its constituents on neuroendocrine responses in the rat. J. Psychopharmacol. 14:(4):2000;360-363.
10. Franklin M., Cowen P.J. Researching the antidepressant actions of hypericum perforatum (St. John's Wort) in animals and man. Pharmacopsychiatry. 34:2001;29-37.
11. 2A agonist, DOI in the rat. Pharmacopsychiatry, in press.
12. Hennessy M., Kelleher D., Spiers J.P., Kavanagh P., Back D., Mulcahy F., Feely J. St John's wort increases expression of P-glycoprotein: implications for drug interactions. Br. J. Clin. Pharmacol. 53:2002;75-82.
13. Karssen A.M., Meijer O.C., Van der Sandt I., Lucassen P.J., De Lange E.C., De Boer A.G., De Kloet E.R. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology. 142:2001;2686-2694.
14. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., Melchart D. St. John's wort for depression - an overview and meta-analysis of randomized clinical trials. Br. Med. J. 313:1997;253-258.
15. Perloff M.D., von Moltke L.L., Stormer E., Shader R.I., Greenblatt D.J. St John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br. J. Pharmacol. 134:2001;1601-1608.
16. Schüle C., Baghai T., Ferrera A., Laakmann G. Neuroendocrine effects of hypericum extract WS 5570 in 12 healthy male volunteers. Pharmacopsychiatry. 34:2001;S127-S133.
17. Steiger A., Von Bardeleben U., Wiedemann K., Holsboer F. Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission. J. Psychiatr. Res. 25:1991;169-177.
18. Van de Vries Marquet R.L., Stoter G., De Bruijn E.A., Eggermont A.M. In vivo model systems in P-glycoprotein-mediated multidrug resistance. Crit. Rev. Clin. Lab. Sci. 35:1998;1-57.
19. Wolkowitz O.M., Reus V.I. Treatment of depression with antiglucocorticoid drugs. Psychosom. Med. 61:1999;698-711.
20. Wonnemann M., Singer A., Müller W.E. Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John's Wort: the role of amiloride sensitive sodium conductive pathways. Neuropsychopharmacology. 23:2000;188-197.